HONG KONG, Jan. 5, 2011 (GLOBE NEWSWIRE) -- The Board of Directors of Sinobiomed Inc. ("Sinobiomed", or "the Company") (Pink Sheets:SOBM) is pleased to announce a strategic partnership with solana HK Limited.
solana .hk which is based in Hong Kong, offers colocation and network facilities, strategic consulting solutions, and value-added voice and data solutions to international carriers and multinational companies
The partnership enables Sinobiomed to utilize solana's extensive telecommunications expertise, and explore opportunities in managed telecommunications services, cloud computing and hosting Software as a Service (SaaS) initiatives in the Asia Pacific region.
George Yu, CEO of Sinobiomed, commented, "As the company transitions into a high-growth business in other industry sectors, the strategic partnership with solana adds value to us on telecommunications platforms and infrastructure which is fundamental to all companies regardless of size or industry focus."
John Madsen, President of solana, adds, "I look forward to working with Sinobiomed as it embarks upon its infrastructure and connectivity strategy in Asia."
FORWARD LOOKING STATEMENTS This news release may include "forward-looking statements" regarding Sinobiomed, and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiomed expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Sinobiomed does not undertake any obligation to update any forward looking statement, except as required under applicable law.
CONTACT: Sinobiomed Inc. INVESTOR RELATIONS: email@example.com Room 4304, 43/F China Resources Building 26 Harbour Road Wan Chai Hong Kong